Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,441 across all filing types
Latest filing 2021-03-30 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
年度股东大会通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2020 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It includes information about the meeting date, location, voting procedures, agenda items such as the 2020 annual report, financial statements, profit distribution plan, and other reports to be discussed at the AGM. The document does not contain the actual annual report or financial statements but rather serves as a formal announcement and invitation to shareholders to attend and vote at the AGM. The presence of detailed voting instructions and proxy forms further supports that this is an AGM Information document rather than the report itself or voting results. Therefore, the appropriate classification is AGM Information (AGM-R).
2021-03-30 Chinese
2020年度公司募集资金存放与使用情况报告
Capital/Financing Update Classification · 95% confidence The document is titled as a 2020 annual report on the company's raised funds deposit and usage situation. It details the amounts raised in 2016 and 2019 through non-public stock issuance, the management and storage of these funds, their actual usage, and compliance with regulatory requirements. It includes detailed financial tables and explanations about the use of funds, approvals, and audit reports from accounting firms. The document is comprehensive and contains substantive financial data and analysis related to the company's fundraising activities and fund usage for the fiscal year 2020. This matches the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes rather than a full annual report or audit report. Therefore, the appropriate classification is CAP.
2021-03-30 Chinese
保荐机构关于2021年度日常关联交易预计事项的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from joint sponsors (华泰联合证券有限责任公司 and 光大证券股份有限公司) regarding the 2021 annual expected related party transactions of 嘉事堂药业股份有限公司. It includes detailed descriptions of related party transactions, pricing policies, and the sponsors' opinions on the fairness and compliance of these transactions. The document is not a full annual report or financial statement but rather a verification or audit opinion related to specific transactions. It does not contain comprehensive financial data or management discussion but focuses on the audit/verification of related party transactions. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is 2473 characters, which is relatively short but contains substantive content beyond a mere announcement or certification, so it is not RPA or RNS. Hence, the classification is AR with high confidence.
2021-03-30 Chinese
关于续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of an accounting firm (Ernst & Young Hua Ming) for the company's 2021 audit services. It details the background of the accounting firm, the audit committee's review, independent directors' opinions, and the board's approval, but it does not contain any actual audit report or financial statements. The document is relatively short (2155 characters) and serves as a formal notice of the intention to reappoint the auditor, pending shareholder approval. This fits the category of an Audit Report / Information announcement rather than the full audit report itself or an annual report. Therefore, the appropriate classification is AR (Audit Report / Information).
2021-03-30 Chinese
2020年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the 2020 annual profit distribution plan of the company 嘉事堂药业股份有限公司. It includes details about the profit distribution proposal, board and supervisory committee approvals, and independent director opinions. The document does not contain full financial statements or comprehensive financial performance data but focuses on the dividend distribution plan and related approvals. It is a formal announcement of the dividend amount and payment plan to shareholders, which fits the definition of a Notice of Dividend Amount (DIV). The document length is short (1526 characters), and it is not a full annual report or earnings release but a specific dividend announcement.
2021-03-30 Chinese
独立董事2020年度述职报告(张晓崧)
Board/Management Information Classification · 95% confidence The document is an independent director's annual performance report for the year 2020. It details the director's attendance at meetings, opinions on company matters, investigations, committee roles, and efforts to protect investor rights. It is a narrative report on governance and oversight activities rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a brief announcement or certification. The content aligns with a management or board-related report focusing on governance and oversight. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3006 characters, which is consistent with a detailed report but not a full annual report or financial supplement.
2021-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.